| Gregory Grant, MD | |
|
3214 Kethley Rd, Shawnee, OK 74804-9625 | |
| (405) 273-5801 | |
| (405) 878-3814 |
| Full Name | Gregory Grant |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 18 Years |
| Location | 3214 Kethley Rd, Shawnee, Oklahoma |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1609918234 | NPI | - | NPPES |
| 200124950A | Medicaid | OK |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 25087 (Oklahoma) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Loving Care In Home Health Services, Llc | Noble, OK | Home health agency |
| Elara Caring Xxiii | Ada, OK | Home health agency |
| Hospice By Loving Care | Noble, OK | Hospice |
| Ssm Health St Anthony Hospital - Shawnee | Shawnee, OK | Hospital |
| Oklahoma Heart Hospital South, Llc | Oklahoma city, OK | Hospital |
| Ssm Health St Anthony Hospital - Oklahoma City | Oklahoma city, OK | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Shawnee Medical Center Clinic, Inc. | 3870405434 | 80 |
News Archive
An analysis of diagnostic test results from the Prospective Multicenter Imaging Study for Evaluation of Chest Pain (PROMISE) trial - in which patients with stable chest pain were randomized to either anatomic or functional testing as an initial diagnostic strategy - showed that the presence and extent of coronary artery disease detected by CT angiography better predicted the risk for future cardiac events than did measures of exercise tolerance or restricted blood flow to the heart muscle.
Cancer-control researchers at The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute and the University of Kentucky aim to increase colorectal cancer screening and follow-up care among underserved individuals in Appalachia through a multi-institutional $5.7 million grant from the National Cancer Institute.
For patients with breast cancer and bone metastases, denosumab delayed skeletal-related side effects five months longer compared to those on zoledronic acid, according to results presented at the 33rd Annual CTRC-AACR San Antonio Breast Cancer Symposium, held Dec. 8-12.
Endocyte Inc., a company developing targeted small-molecule drug conjugates, will present results of an interim analysis from a randomized phase II clinical trial in women with platinum-resistant ovarian cancer on Sunday (June 6) during the 46th annual meeting of the American Society of Clinical Oncology in Chicago.
› Verified 6 days ago
| Entity Name | Shawnee Medical Center Clinic, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1881648285 PECOS PAC ID: 3870405434 Enrollment ID: O20031103000239 |
News Archive
An analysis of diagnostic test results from the Prospective Multicenter Imaging Study for Evaluation of Chest Pain (PROMISE) trial - in which patients with stable chest pain were randomized to either anatomic or functional testing as an initial diagnostic strategy - showed that the presence and extent of coronary artery disease detected by CT angiography better predicted the risk for future cardiac events than did measures of exercise tolerance or restricted blood flow to the heart muscle.
Cancer-control researchers at The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute and the University of Kentucky aim to increase colorectal cancer screening and follow-up care among underserved individuals in Appalachia through a multi-institutional $5.7 million grant from the National Cancer Institute.
For patients with breast cancer and bone metastases, denosumab delayed skeletal-related side effects five months longer compared to those on zoledronic acid, according to results presented at the 33rd Annual CTRC-AACR San Antonio Breast Cancer Symposium, held Dec. 8-12.
Endocyte Inc., a company developing targeted small-molecule drug conjugates, will present results of an interim analysis from a randomized phase II clinical trial in women with platinum-resistant ovarian cancer on Sunday (June 6) during the 46th annual meeting of the American Society of Clinical Oncology in Chicago.
› Verified 6 days ago
| Entity Name | Ssm Health Care Of Oklahoma, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033283932 PECOS PAC ID: 6709771207 Enrollment ID: O20040216000184 |
News Archive
An analysis of diagnostic test results from the Prospective Multicenter Imaging Study for Evaluation of Chest Pain (PROMISE) trial - in which patients with stable chest pain were randomized to either anatomic or functional testing as an initial diagnostic strategy - showed that the presence and extent of coronary artery disease detected by CT angiography better predicted the risk for future cardiac events than did measures of exercise tolerance or restricted blood flow to the heart muscle.
Cancer-control researchers at The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute and the University of Kentucky aim to increase colorectal cancer screening and follow-up care among underserved individuals in Appalachia through a multi-institutional $5.7 million grant from the National Cancer Institute.
For patients with breast cancer and bone metastases, denosumab delayed skeletal-related side effects five months longer compared to those on zoledronic acid, according to results presented at the 33rd Annual CTRC-AACR San Antonio Breast Cancer Symposium, held Dec. 8-12.
Endocyte Inc., a company developing targeted small-molecule drug conjugates, will present results of an interim analysis from a randomized phase II clinical trial in women with platinum-resistant ovarian cancer on Sunday (June 6) during the 46th annual meeting of the American Society of Clinical Oncology in Chicago.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Gregory Grant, MD Po Box 849, Shawnee, OK 74802-0849 Ph: (405) 273-5801 | Gregory Grant, MD 3214 Kethley Rd, Shawnee, OK 74804-9625 Ph: (405) 273-5801 |
News Archive
An analysis of diagnostic test results from the Prospective Multicenter Imaging Study for Evaluation of Chest Pain (PROMISE) trial - in which patients with stable chest pain were randomized to either anatomic or functional testing as an initial diagnostic strategy - showed that the presence and extent of coronary artery disease detected by CT angiography better predicted the risk for future cardiac events than did measures of exercise tolerance or restricted blood flow to the heart muscle.
Cancer-control researchers at The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute and the University of Kentucky aim to increase colorectal cancer screening and follow-up care among underserved individuals in Appalachia through a multi-institutional $5.7 million grant from the National Cancer Institute.
For patients with breast cancer and bone metastases, denosumab delayed skeletal-related side effects five months longer compared to those on zoledronic acid, according to results presented at the 33rd Annual CTRC-AACR San Antonio Breast Cancer Symposium, held Dec. 8-12.
Endocyte Inc., a company developing targeted small-molecule drug conjugates, will present results of an interim analysis from a randomized phase II clinical trial in women with platinum-resistant ovarian cancer on Sunday (June 6) during the 46th annual meeting of the American Society of Clinical Oncology in Chicago.
› Verified 6 days ago
Dr. David Lewis Hadley, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1920 N Broadway Ave, Shawnee, OK 74804 Phone: 405-273-7879 Fax: 405-273-7885 | |
Dr. Lara Del Mashek, M.D Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1102 W Macarthur St, Shawnee, OK 74804 Phone: 405-273-2270 Fax: 405-878-3468 | |
Dr. Monika Durska-keller, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2029 Gordon Cooper Dr, Shawnee, OK 74801 Phone: 405-878-5850 | |
Gaynell Schieber Anderson, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1102 W Macarthur St, Shawnee, OK 74804 Phone: 405-878-8110 Fax: 405-214-1551 | |
Russell Craig Click, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3204 Medical Park Dr, Shawnee, OK 74804 Phone: 405-878-6800 Fax: 405-878-6831 | |
Mitchell A Wolf, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3214 Kethley Rd, Shawnee, OK 74804 Phone: 405-273-5801 Fax: 405-878-3794 | |
Dr. George A Vascellaro, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 781 Grand Casino Blvd, Shawnee, OK 74804 Phone: 405-964-5770 Fax: 405-964-5788 |